Paid Clinical Trials in Huntersville, NC
As of August 2026, 66 paid clinical trials are recruiting in Huntersville, North Carolina. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Huntersville offers studies at sites including Carolina BioOncology Institute for conditions such as Idiopathic Hypersomnia, Narcolepsy Type 2, Advanced Solid Tumor, Advanced Solid Tumors. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Huntersville
Trials by drug in Huntersville
Filter results
Newly added in Huntersville
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
64 clinical trials
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Study of XB010 in Subjects With Solid Tumors
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
First In Human Study of CX-2051 in Advanced Solid Tumors
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
A Study of DM002 in Patients With Advanced Solid Tumors
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
A Study of HS-20110 in Participants With Advanced Solid Tumors
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
Top Research Study Locations in Huntersville
Researchers run research studies in Huntersville, NC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Carolina BioOncology Institute | Advanced Solid Tumors, Ovarian Cancer, Solid Tumor, Adult | 16 |
| Novant Health Cancer Institute - Huntersville | Anatomic Stage II Breast Cancer AJCC v8, AL Amyloidosis, Advanced Lung Non-Squamous Non-Small Cell Carcinoma | 10 |
| Levine Cancer Institute - Huntersville | Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 5 |
| Novant Health Presbyterian Medical Center Huntersville | Anaplastic Large Cell Lymphoma, ALK-Negative, Breast Cancer, Follicular Helper T-Cell Lymphoma | 4 |
| Huntersville, North Carolina | Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia | 3 |
| Alkermes Investigational Site | Narcolepsy Type 2, Idiopathic Hypersomnia, Narcolepsy Type 1 | 2 |
| Carolina BioOncology Institute, LLC | Advanced Solid Tumor, Colorectal Neoplasms, Endometrial Neoplasms | 2 |
| Stern Research Partners, LLC | Asthma, Idiopathic Hypersomnia | 2 |
| Carolina BioOncology | Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma, Cancer | 2 |
| Takeda | Idiopathic Hypersomnia, Narcolepsy Type 2 | 2 |
| ARSM Research, LLC | Narcolepsy Type 1 | 1 |
| Advanced Respiratory and Sleep Medicine | OSA | 1 |
| Alkermes Investigator Site | Idiopathic Hypersomnia | 1 |
| Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center | Advanced Solid Tumors | 1 |
| Carolina BioOncology Institute, PLLC | Solid Tumor, Adult | 1 |
| Clinical Trial Site | Advanced Solid Tumor | 1 |
| Dren Investigational Site | Castrate Resistant Prostate Cancer, Cervical Cancer, Endometrial Cancer | 1 |
| Exelixis Clinical | Solid Tumors | 1 |
| H/K/B Surgery | Capsular Contracture Associated With Breast Implant, Capsular Contracture Grade III, Capsular Contracture Grade IV | 1 |
| J Chichetti PLLC 2 | Malocclusion | 1 |
| Levine Cancer Institute | Metastatic Breast Cancer | 1 |
| Onsite Clinical Solutions - Huntersville | Overweight or Obesity, Psoriasis | 1 |
| Piedmont Plastic Surgery and Dermatology - Huntersville | Atopic Dermatitis | 1 |
| Piedmont Plastic Surgery and Dermatology | Atopic Dermatitis | 1 |
| Rosedale Health and Wellness | HIV-1-infection | 1 |
Active & Upcoming Studies in Huntersville (2026)
Recruiting trials in Huntersville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (34 active studies)
- A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors · Phase 1, Phase 2 · Arvinas Inc.
- A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors · Phase 1, Phase 2 · DualityBio Inc.
Vaccines (1 active study)
HIV / STI (1 active study)
- A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 · Phase 2 · Gilead Sciences
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Diabetes & metabolic (1 active study)
Common conditions studied in Huntersville
- Idiopathic Hypersomnia (6 active studies)
- Narcolepsy Type 2 (6 active studies)
- Advanced Solid Tumor (5 active studies)
- Advanced Solid Tumors (5 active studies)
- Narcolepsy Type 1 (5 active studies)
- Cervical Cancer (4 active studies)
Leading research sponsors in Huntersville
- NRG Oncology
- AbbVie
- Alkermes, Inc.
- Alliance for Clinical Trials in Oncology
- Centessa Pharmaceuticals (UK) Limited
Frequently asked questions
How many paid clinical trials are currently recruiting in Huntersville?
There are approximately 66 recruiting clinical trials in Huntersville, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Huntersville pay participants?
Most recruiting trials in Huntersville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Huntersville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Huntersville?
The most common conditions under active study in Huntersville include Idiopathic Hypersomnia (6), Narcolepsy Type 2 (6), Advanced Solid Tumor (5), Advanced Solid Tumors (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Huntersville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Huntersville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Huntersville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Huntersville?
Recruiting research sites in Huntersville include Carolina BioOncology Institute, Novant Health Cancer Institute - Huntersville, Levine Cancer Institute - Huntersville, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Huntersville right now?
The largest active categories in Huntersville are Cancer & tumors (34), Vaccines (1), HIV / STI (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.